Study to Evaluate the Safety, Pharmacokinetics and Efficacy of STI-2020 (COVI-AMG™) in Outpatients With COVID-19

NCT04584697 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Different study will be conducted

Conditions

Covid19

Interventions

BIOLOGICAL: COVI-AMG
DRUG: Placebo

Sponsor

Sorrento Therapeutics, Inc.